RTS,S; World’s First Malaria Vaccine

More than 17,000 girls given the the HPV Vaccine

Malaria Vaccine is biologically prepared to provide active acquire immunity to malaria disease. Malaria is a mosquito-borne infectious disease that affects humans and other animals. It is a disease that can be life-threatening when not properly treated. However, Malaria like every other disease has its symptoms. Malaria symptoms include; fever, tiredness, vomiting, and headaches but in severe cases, an infected patient can have yellow skin, seizures, coma or death. Malaria so far, as become a common disease across Africa with two out of three people being infected. There are those who have become so associated with the symptoms of malaria that they do not worry anymore. Moreso, there are those who now indulge in self-medication whenever they feel they are reacting to Malaria infections.

Fight against Malaria before they introduced the vaccine.

The notion that there is no medication to get rid of Malaria from anyone who is infected is widely accepted across Africa. Although, there are so many antibiotics produced and marketed daily in a fight against malaria virus the virus is resistent to some. But then the cause of Malaria which is mosquito infection is difficult to control. Hence one who have been cured of malaria can have the need for another cure in let us say a 4months interval. This is because after being cured they are exposed to mosquito bites that reinfect them.

Moreso, there are specific drugs used to cure malaria parasites but a person may not be cured if exposed to the wrong drug. And when not treated it can continue to grow until it gets to a severe stage. Although, there are ways to prevent mosquito bites such as sleeping in mosquito nets and applying insect repellent on skin. These preventive measures do not cure Malaria infection but they prevent individuals against Mosquito bites. One could wonder that with the advance of medical science can’t a vaccine be generated?

Medical Science has created a Malaria Vaccine

RTS, S/AS01 with the trade name Mosquirix is a recombinant protein-based malaria vaccine. It is the world’s first malaria vaccine to be licensed for use against a human parasitic disease. According to google Moreso, it gained its approval from the European regulators in July 2015. Although, this malaria vaccine was first launched in Malawi on the 23 of April in 2019.  However, Ghana and Kenya also launched this vaccine in their respective countries on the 30th of April and the 13th of September. These countries were the first in Africa to make plans on having RTS,S available to children from the age of 2 and above.

The world’s first Malaria Vaccine called RTS,S/AS01 (RTS,S) has been shown to reduce Malaria in children. This special vaccine acts against the deadliest malaria parasite(Plasmonic falciparum) in Africa and the World. Finally this plasmodium spread caused by a mosquito can be reduced in children, it is a relief to Africa and the globe. However, the World Health Organization (WHO) does not recommend the routine use of RTS,S vaccine. WHO infants between 6 and 12 weeks old should not be given RTS,S on routine. During clinical trials, RTS,S found to prevent 4 in 10 malaria cases, including 3 in 10 cases of life-threatening severe malaria cases. According to who.int


Related Posts